Benzinga | Oct 6, 2020 08:01AM EDT

Karyopharm Announces Selinexor Clinical Data to be Presented at the International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group Virtual Conference on Therapeutics for COVID-19

Encouraging Anti-Viral and Anti-Inflammatory Activity Demonstrated in a Subset of Patients in a Study of Low Dose Selinexor in Hospitalized Patients with Severe COVID-19 ?

? A Case Report From a COVID-19 Patient Treated with Selinexor Now Also Published in the Annals of Case Reports -